ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 287

Variation in Healthcare Utilization by Region and Number of Rheumatologists Per State Among Pediatric Medicaid Patients with Lupus Nephritis Prior to End-Stage Renal Disease in the United States, 2000-2004

Linda T. Hiraki1, Candace H. Feldman2, Graciela S. Alarcon3, Jun Liu4, Michael A. Fischer5, Wolfgang C. Winkelmayer6 and Karen H. Costenbader7, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard School of Public Health, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Boston, MA, 3Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, 5Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, 6Division of Nephrology, Stanford University School of Medicine, Stanford, CA, 7Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Access to care, Lupus nephritis, Pediatric rheumatology, socio-economic inequities and utilization review

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Unequal healthcare access and utilization may contribute to the striking sociodemographic disparities seen in outcomes for children with lupus nephritis. Medicaid is the U.S. federal-state program providing health insurance to low-income children and parents. We investigated variation in US nationwide frequencies of emergency department (ED), outpatient and inpatient visits among children with lupus nephritis enrolled in Medicaid, 2000-2004, in the months preceding the development of end-stage renal disease (ESRD).

Methods: We identified all children aged 3 to <18 years with SLE (≥3 ICD-9 codes of 710.0, each >30 days apart) in the Medicaid Analytic eXtract (MAX) from 2000-2004. This dataset contains all outpatient and inpatient Medicaid claims for enrollees in 47 U. S. states and the District of Columbia. These data were linked to those from the U.S. Renal Data System, which includes information on essentially all ESRD patients in the U.S., for the same years. We compared utilization of ED, outpatient and inpatient visits per year in the Medicaid enrolled time prior to development of ESRD for those in different categories according to: region of residence in the US, residence in a US designated Health Professional Shortage Area (HPSA), and quartiles of rheumatologist number in state of residence. Multivariable generalized linear models were adjusted for each of these variables along with enrollee age, race, sex, months of Medicaid enrollment and a validated measure of socioeconomic status combining seven US Census zip code level variables.

Results: Of the 254 pediatric lupus nephritis patients identified, the mean age was 14.2 (± 2.4) years; 72% were female, 61% were African American and 19% were Hispanic. Mean duration of Medicaid enrollment prior to the onset of ESRD was 28.5 (±16.4) months. Among all patients there was an average of 2.0 (± 2.4) ED visits per year, 10.8 (± 9.4) outpatient visits and 2.4 (± 2.6) inpatient visits. In multivariable adjusted models, children residing in areas with the lowest quartile of rheumatologists per state had on average 4.2 more ED visits per year (p=0.001) compared with those in the highest quartile of rheumatologists per state. Children residing in the West had on average 5.4 more outpatient visits per year (p= 0.03), and those in the South had 1.2 fewer inpatient visit per year (p= 0.03) than those in the Northeast. We did not observe statistically significant variation in utilization by HPSA.

Conclusion: We observed significant differences in health care utilization among children enrolled in Medicaid with lupus nephritis prior to the onset of ESRD. Low number of rheumatologists per state was the most important factor associated with more annual ED visits. This finding in addition to regional variation in annual inpatient and outpatient visits within this medically complex and low-income Medicaid population deserves further investigation.


Disclosure:

L. T. Hiraki,
None;

C. H. Feldman,
None;

G. S. Alarcon,
None;

J. Liu,
None;

M. A. Fischer,
None;

W. C. Winkelmayer,
None;

K. H. Costenbader,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/variation-in-healthcare-utilization-by-region-and-number-of-rheumatologists-per-state-among-pediatric-medicaid-patients-with-lupus-nephritis-prior-to-end-stage-renal-disease-in-the-united-states-2000/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology